CLINICAL_TRIALS
trial_result
· 2014-02-20
Clinical Trial Update: Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration [NA]
Summary
Long-term results from a completed trial evaluating intravitreal bevacizumab for neovascular age-related macular degeneration.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Vienna | Conditions: Neovascular Age-related Macular Degeneration | NA | Status: COMPLETED | Results posted: 2014-02-20